Cargando…

The kinetic profiles of copeptin and mid regional proadrenomedullin (MR-proADM) in pediatric lower respiratory tract infections

BACKGROUND: Kinetics of copeptin and mid regional proadrenomedullin (MR-proADM) during febrile pediatric lower respiratory tract infections (LRTI) are unknown. We aimed to analyze kinetic profiles of copeptin and MR-proADM and the impact of clinical and laboratory factors on those biomarkers. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baumann, Philipp, Fuchs, Aline, Gotta, Verena, Ritz, Nicole, Baer, Gurli, Bonhoeffer, Jessica M., Buettcher, Michael, Heininger, Ulrich, Szinnai, Gabor, Bonhoeffer, Jan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8912143/ https://www.ncbi.nlm.nih.gov/pubmed/35271609 http://dx.doi.org/10.1371/journal.pone.0264305

Ejemplares similares

Procalcitonin for Diagnostics and Treatment Decisions in Pediatric Lower Respiratory Tract Infections
por: Baumann, Philipp, et al.
Publicado: (2017)

Drivers of antibiotic prescribing in children and adolescents with febrile lower respiratory tract infections
por: Gotta, Verena, et al.
Publicado: (2017)

Mid-Regional Proadrenomedullin (MR-proADM) and Microcirculation in Monitoring Organ Dysfunction of Critical Care Patients With Infection: A Prospective Observational Pilot Study
por: Domizi, Roberta, et al.
Publicado: (2021)

MR-proADM as prognostic factor of outcome in COVID-19 patients
por: Sozio, Emanuela, et al.
Publicado: (2021)

MR-proADM as Prognostic Factor of Outcome in COVID-19 Patients
por: Cameli, Paolo, et al.
Publicado: (2023)

Procalcitonin Guidance to Reduce Antibiotic Treatment of Lower Respiratory Tract Infection in Children and Adolescents (ProPAED): A Randomized Controlled Trial
por: Baer, Gurli, et al.
Publicado: (2013)

Mid-Regional Pro-Adrenomedullin (MR-proADM) as a Biomarker for Sepsis and Septic Shock: Narrative Review
por: Önal, Uğur, et al.
Publicado: (2018)

Dataset of the associations of aldosterone to renin ratio with MR-proANP and MR-proADM
por: Then, Cornelia, et al.
Publicado: (2016)

MR-proADM and MR-proANP levels in patients with acute pulmonary embolism
por: Öner, Önsel, et al.
Publicado: (2020)

Prognostic value of copeptin and mid‐regional proadrenomedullin in COVID‐19‐hospitalized patients
por: Indirli, Rita, et al.
Publicado: (2022)

Short‐Term Influence of Radiofrequency Ablation on NT‐proBNP, MR‐proANP, Copeptin, and MR‐proADM in Patients With Atrial Fibrillation: Data From the Observational SMURF Study
por: Charitakis, Emmanouil, et al.
Publicado: (2016)

Circulating MR-proADM levels, as an indicator of endothelial dysfunction, for early risk stratification of mid-term mortality in COVID-19 patients
por: García de Guadiana-Romualdo, Luis, et al.
Publicado: (2021)

Acute exacerbations of copd (AECOPD) in the emergency room (ER): prognostic value of proadrenomedulline (PROADM)
por: Dres, M, et al.
Publicado: (2015)

Mid-regional pro-adrenomedullin (MR-proADM), a marker of positive fluid balance in critically ill patients: results of the ENVOL study
por: Vigué, Bernard, et al.
Publicado: (2016)

Prognostic value of mid-regional pro-adrenomedullin (MR-proADM) in patients with community-acquired pneumonia: a systematic review and meta-analysis
por: Liu, Dan, et al.
Publicado: (2016)

Effectiveness of mid-regional pro-adrenomedullin (MR-proADM) as prognostic marker in COVID-19 critically ill patients: An observational prospective study
por: Montrucchio, Giorgia, et al.
Publicado: (2021)

Semimechanistic modeling of copeptin and aldosterone kinetics and dynamics in response to rehydration treatment for diabetic ketoacidosis in children
por: Otto, Marije E., et al.
Publicado: (2022)

Application of MR-ProADM to predict prevention of hospitalisation, derived from a multi-centre study
por: Cullinan, Milo, et al.
Publicado: (2019)

Role of MR-proADM in the risk stratification of COVID-19 patients assessed at the triage of the Emergency Department
por: Minieri, Marilena, et al.
Publicado: (2021)

1542. MR-proADM Biomarker Predicts COVID-19 Clinical Outcomes: a US-based Cohort Study
por: Mansour, Michael
Publicado: (2022)

Proadrenomedullin and copeptin in pediatric pneumonia: a prospective diagnostic accuracy study
por: Alcoba, Gabriel, et al.
Publicado: (2015)

Monocyte, Lymphocyte and Neutrophil Ratios – Easy-to-Use Biomarkers for the Diagnosis of Pediatric Tuberculosis
por: Kissling, Mirjam, et al.
Publicado: (2023)

Predictive Value of MR-proADM in the Risk Stratification and in the Adequate Care Setting of COVID-19 Patients Assessed at the Triage of the Emergency Department
por: Minieri, Marilena, et al.
Publicado: (2022)

Utility of Procalcitonin (PCT) and Mid regional pro-Adrenomedullin (MR-proADM) in risk stratification of critically ill febrile patients in Emergency Department (ED). A comparison with APACHE II score
por: Travaglino, Francesco, et al.
Publicado: (2012)

Association between MR-proADM concentration and treatment intensity of antihypertensive agents in chronic kidney disease patients with insufficient blood pressure control
por: Iwao, Motoshi, et al.
Publicado: (2021)

Association of circulating MR-proADM with all-cause and cardiovascular mortality in the general population: Results from the KORA F4 cohort study
por: Gar, Christina, et al.
Publicado: (2022)

Associations of the vasoactive peptides CT-proET-1 and MR-proADM with incident type 2 diabetes: results from the BiomarCaRE Consortium
por: Sujana, Chaterina, et al.
Publicado: (2022)

Can mid-regional pro-adrenomedullin (MR-proADM) increase the prognostic accuracy of NEWS in predicting deterioration in patients admitted to hospital with mild to moderately severe illness? A prospective single-centre observational study
por: Graziadio, Sara, et al.
Publicado: (2018)

Response to: MR-proADM has a good ability to predict mortality in critically ill patients with SARS-CoV-2 pneumonia: Beware of some potential confounders!
por: van Oers, Jos A.H., et al.
Publicado: (2022)

Systematic review with meta-analysis of mid-regional pro-adrenomedullin (MR-proadm) as a prognostic marker in Covid-19-hospitalized patients
por: Fialek, Bartosz, et al.
Publicado: (2023)

MR‐proADM as a Prognostic Marker in Patients With ST‐Segment–Elevation Myocardial Infarction—DANAMI‐3 (a Danish Study of Optimal Acute Treatment of Patients With STEMI) Substudy
por: Falkentoft, Alexander C., et al.
Publicado: (2018)

MR-proADM has a good ability to predict 28-day mortality in critically ill patients with SARS-CoV-2 pneumonia: Beware of some potential confounders!
por: Honore, Patrick M., et al.
Publicado: (2022)

Copeptin Release in Arterial Hypotension and Its Association with Severity of Disease in Critically Ill Children
por: Baumann, Philipp, et al.
Publicado: (2022)

Red cell distribution width as a prognostic marker for complications of community-acquired pneumonia in children: a comparison with Proadrenomedullin and Copeptin
por: Moustafa, Asmaa N., et al.
Publicado: (2023)

MR-Proadrenomedullin as biomarker of renal damage in urinary tract infection in children
por: Peñalver Penedo, Rafael, et al.
Publicado: (2021)

Mid-Regional Proadrenomedullin as a New Biomarker of Kidney and Cardiovascular Diseases—Is It the Future?
por: Czajkowska, Katarzyna, et al.
Publicado: (2021)

The TRIAGE-ProADM Score for an Early Risk Stratification of Medical Patients in the Emergency Department - Development Based on a Multi-National, Prospective, Observational Study
por: Kutz, Alexander, et al.
Publicado: (2016)

Procalcitonin, MR-Proadrenomedullin, and Cytokines Measurement in Sepsis Diagnosis: Advantages from Test Combination
por: Angeletti, Silvia, et al.
Publicado: (2015)

Superior accuracy of mid-regional proadrenomedullin for mortality prediction in sepsis with varying levels of illness severity
por: Andaluz-Ojeda, David, et al.
Publicado: (2017)

Long-Term Outcomes of Acute Osteoarticular Infections in Children
por: Manz, Nora, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_buqsrafd7iog41mca4clin2mu6